HOTGEN COVID-19 ANTIGEN HOME TEST AT-HOME USE RESULTS IN 15 MINS
Live / Registered — Registered (as of 04 Feb 2025)
What this means for you
Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97650014
- Registration number
- 7681112
- Mark type
- Design + words
- Filed
- 27 Oct 2022
- Published for opposition
- 20 Feb 2024
- Registered
- 04 Feb 2025
- Attorney of record
- Gregory P Brummett
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of COVID-19; diagnostic preparations for medical and veterinary use for diagnosing COVID-19; sanitary preparations for medical purposes for preventing the spread of COVID-19; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in testing COVID-19 antigens
Owner
- Beijing Hotgen Biotech Co., Ltd., Beijing, CN
- Beijing Hotgen Biotech Co., Ltd., Beijing, CN
- Beijing Hotgen Biotech Co., Ltd., Beijing, CN
Prosecution history
- 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 10 Jan 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jan 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Oct 2024 — USE AMENDMENT FILED
- 01 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Oct 2024 — TEAS STATEMENT OF USE RECEIVED
- 16 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Feb 2024 — PUBLISHED FOR OPPOSITION
- 31 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED